CHICAGO (MarketWatch) — Among Thursday’s biggest gaining and declining stocks:
Gainers
Apogee Enterprises Inc. (US:APOG) rose 4% after the industrial glass maker lifted its full-year earnings forecast.
Cleveland BioLabs Inc. (US:CBLI) rose up 4% after it and its Incuron LLC subsidiary announced positive results for their CBL0137 cancer drug in the treatment of animals that had neuroblastoma.
Eagle Bulk Shipping shares (US:EGLE) added 31%. Eagle said it reached an agreement with a syndicate of its lenders, led by Royal Bank of Scotland Group PLC. The deal allows the dry-bulk shipper to resolve all outstanding issues with lenders and improves its position amid an ongoing downturn in shipping markets, the company said. Read more about the Eagle Bulk Shipping financing deal.
Federal Signal Corp. (US:FSS) climbed almost 19% after it said it would sell its electronic-toll unit to 3M CO. MM for $110 million in cash.
Onyx Pharmaceuticals Inc. (US:ONXX) rose 43%. The firm said it has received a positive vote from an FDA panel on one of its drugs.
Osiris Therapeutics Inc. (US:OSIR) shares rose 4.6%. The company’s shares have been on a roll since last week, when the company announced New Zealand regulators had approved its stem-cell therapy Prochymal for the treatment of acute graft-vs-host disease in children who have undergone bone marrow transplants. Last month, Canadian regulators were the first to approve the product.
Sun Healthcare shares (US:SUNH) added almost 37%. Genesis HealthCare LLC will acquire Sun for $8.50 a share, a 38% premium over Sun’s closing price Wednesday. The companies value the deal at approximately $275 million. Read more about the Sun Healthcare–Genesis HealthCare deal.
Decliners
Shares of Bed, Bath & Beyond (US:BBBY) fell 17% after the retailer said late Wednesday that it had surpassed expectations with 15% higher profit in the first quarter, but it broke from tradition with a downbeat outlook, middling same-store-sales growth and gross-margin contraction. Read more about Bed, Bath & Beyond’s earnings and reactions.
CarMax Inc. (US:KMX) was down more than 7% after its report of first-quarter earnings that fell short of most analyst forecasts.
Celgene shares (US:CELG) fell 11.5% after the company said it’s withdrawing its new-indication submission to European regulators for its Revlimid medicine for multiple myeloma, a cancer that affects a type of white blood cells.
Clarcor Inc. (US:CLC) fell almost 9% after the company reported softer-than-expected second quarter results and trimmed its full-year forecasts.
Key Energy shares (US:KEG) fell nearly 18% after the company projected weaker growth rates and revised lower its financial forecast for the second quarter, reflecting a slowdown in its domestic business.
Micron Technology Inc. (US:MU) gave up 7.8% after the chip maker reported a loss, taking a hit from weak pricing for memory chips.
Red Hat Inc. (US:RHT) shares fell more than 6% on a disappointing fiscal second-quarter outlook.
http://articles.marketwatch.com/2012-06-21/ma...-forecasts
